Supplementary information Distinct functions of serial metal binding domains in the Escherichia coli P1B-ATPase CopA Steffen L. Drees, Dominik F. Beyer, Christina Lomscher, Mathias Lübben List of Contents Supplementary Tables Table S1. Co-complementation of E. coli DC 194 with variants of copA and mbd1/mbd2/copZBsu. Table S2. PCR Primers used for cloning work. Table S3. Outline of the generated strains/plasmid combinations. Supplementary Figures Figure S1. SDS PAGE survey of protein purifications. Figure S2. Copper dependent steady state kinetics of N-terminally truncated variants of CopA. Figure S3. Growth of the used E. coli strains in LB medium with CuSO4 Figure S4. Determination of MBD affinities to copper - complete. Figure S5. Analytical gel filtrations for copper transfer between MBDs and ΔN1/2CopA. Figure S6. Activation of ΔN1/2CopA in response to the addition of copper providing ligands. Figure S3. pAC-BAD-CopA expression plasmid. Supplementary Experimental Procedures Determination of reduced protein content Supplementary References 1 Table S1. Co-complementation of the copA defective E. coli strain DC194 expressing variants of copA (pAC-BAD vector) with pBAD based vectors producing the MBD1 fragment, C14/17S MBD1 or the copper chaperone CopZ from Bacillus subtilis. Cultures were inoculated to an OD of approx 0.005 and cultivated in LB medium with antibiotics and copper supplementation at 37°C for 12 hours. OD600 after 12h cultivation pBAD (mock) a pBAD::mbd1 pBAD::C14/17S-mbd1 -Cu + Cu c -Cu + Cu c -Cu + Cu c -Cu + Cu c pACBAD::(mock) b pAC-BAD::copA 2.550 ±0.186 0.161 ±0.039 2.628 ±0.183 0.138 ±0.082 2.622 ±0.240 0.161 ±0.106 2.422 ±0.262 0.239 ±0.205 2.554 ±0.164 2.057 ±0.382 2.567 ±0.182 2.376 ±0.646 2.665 ±0.182 1.977 ±0.454 2.577 ±0.216 2.542 ±0.263 pAC-BAD::∆N1copA pAC-BAD::∆N1 C110/113S-copA pACBAD::∆N1/2copA 2.615 ±0.179 0.523 ±0.137 2.569 ±0.224 1.996 ±0.615 2.617 ±0.178 0.625 ±0.422 2.471 ±0.195 2.504 ±0.230 2.644 ±0.205 0.411 ±0.095 2.642 ±0.186 0.611 ±0.250 2.582 ±0.270 0.473 ±0.275 - - 2.542 ±0.222 0.291 ±0.102 2.604 ±0.164 0.537 ±0.284 2.608 ±0.181 0.350 ±0.284 - - a, b c pBAD::copZBsu control plasmid constructs, without gene inserted to expression cassette CuSO4 was present at a concentration of 3 mM Table S2. PCR Primers used for cloning work. Name 5’copA 3’copA 5’N1copA 5’N1/2copA 5’C14/17S 3’C14/17S 5’C110/113S 3’C110/113S 3’mbd1 5’mbd2 3’mbd2 5’BAD-trans-NsiI 3’BAD-trans-NsiI 5’CopZ 5’CopZ 2 sequence 5’->3’ gcgcgcccatggctagctggagccac gcgcgcggatccttattccttcggtttaaaccgcagc gccatggcgaaaccgctggcggagtc gccatggcgaaaccgctggcggagtc ctgtccagcggtcacagcg cgctgtgaccgctggacag gagcagcgccagcagtgtc gacactgctggcgctgctc gcgggatccgcggttaagcctttgggtggc ccatggatgacagccagcagttgc aagcttaatcttcaatcgcttccgcgcc gcgcatgcatcccgccattcagagaagaaacc cgcgatgcatgtcgacggagctcgaattcgg gcccatggaacaaaaaacattgcaag caagcttacttggctacgtcatagc Table S3. Outline of the generated strains/plasmid combinations. Strain name DC194 DC194-CopA DC194-N1CopA DC194-C110/113SN1CopA DC194-N1/2CopA DC194-MBD1 DC194-CopA-MBD1 DC194-N1CopAMBD1 DC194-C110/113SN1CopA-MBD1 DC194-N1/2CopA-MBD1 DC194-CS-MBD1 DC194-CopA-CS-MBD1 DC194-N1CopA-CS-MBD1 DC194-C110/113SN1CopA-CS-MBD1 DC194-N1/2CopA-CS-MBD1 DC194-CS-MBD1 DC194-CopZ DC194-CopA-CopZ DC194-N1CopA-CopZ 3 plasmid 1 pBAD-His-MycA pBAD-His-MycA pBAD-His-MycA pBAD-His-MycA pBAD-His-MycA pBAD-His-MBD1 pBAD-His-MBD1 pBAD-His-MBD1 pBAD-His-MBD1 pBAD-His-MBD1 pBAD-His-C14/17SMBD1 pBAD-His-C14/17SMBD1 pBAD-His-C14/17SMBD1 pBAD-His-C14/17SMBD1 pBAD-His-C14/17SMBD1 pBAD-His-C14/17SMBD1 pBAD-His-CopZ pBAD-His-CopZ pBAD-His-CopZ plasmid 2 pAC-BAD-empty pAC-BAD-CopA pAC-BAD-N1CopA pAC-BAD-C110/113SN1CopA pAC-BAD-N1/2CopA pAC-BAD-empty pAC-BAD-CopA pAC-BAD-N1CopA pAC-BAD-C110/113SN1CopA pAC-BAD-N1/2CopA pAC-BAD-empty pAC-BAD-CopA pAC-BAD-N1CopA pAC-BAD-C110/113SN1CopA pAC-BAD-N1/2CopA pAC-BAD-empty pAC-BAD-empty pAC-BAD-CopA pAC-BAD-N1CopA Fig. S1. SDS PAGE survey of protein purifications. A ΔN1/2CopA with membranes (5), detergent solubilized membrans (6), membrane proteins (7) and isolated ΔN 1/2CopA (8). B Purified CopA variants, wt CopA (1), ΔN1CopA (2) and ΔN1/2CopA (3). C Purification of MBD1 with cell extracts, pellets and supernatants (3-6), after strep-chromatography (7) and after gel filtration (8). Fig. S2. Copper dependent steady state kinetics of the N-terminally truncated variants of CopA. KM values were for 5.4±0.6 µM for CopA, 8.7±0.6 µM for N1CopA and 31.9±5. µM for N1/2CopA. Curve fitting was performed according to the Michaelis Menten model. Due to the atypical decrease of ATP hydrolysis activity at high copper concentrations, data were weighted for the curve fitting (linear decrease from 100 % at 40 µM to to 20 % at 200 µM). vmax and ½ vmax are indicated by grey lines. Squares/dashed line – wild type CopA, triangles/dash-dotted line - ΔN1CopA, circles/solid line - ΔN1/2CopA. Error bars denote standard errors over three measurements. 4 Fig. S3. Growth of the used E. coli strains in LB medium supplied with the denoted concentrations of CuSO 4. OD was measured after overnight growth, strain DC194 pAC-BAD::copA was supplemented with 0.0002 % arabinose. Fig. S4. Determination of MBD affinities to copper by competitive titration against the high affinity chelator BCS. Charts display exemplary titration data. Titrations against 600 µM BCS (A), 400 µM BCS (B), 200 µM BCS (C) and 800 µM BCS (D) were fitted after an appropriate model. 5 Fig. S5. Analytical gel filtrations for estimation of copper transfer between MBDs and ΔN 1/2CopA. Charts in A and B display UV absorption and conductivity readouts of chromatographies. Shadings indicate pointwise standard errors from four experiment repeats. A copper transfer from MBD2 to ΔN1/2CopA, B copper transfer from MBD2 to ΔN1/2CopA, C SDS-PAGE analysis of A. As shown, high salt conditions seem to suffice to suppress interactions of ΔN1/2CopA and MBDs. Fig. S6. Activation of ΔN1/2CopA in response to the addition of copper providing ligands. Sample compositions are denoted in the plot. ATP hydrolysis was monitored by HPLC quantification of ADP. Errorbars reflect standard errors from triplicate determination. 6 Fig. S7. pAC-BAD-CopA expression plasmid. Significant features are highlighted and labelled within the scheme. Supplementary Experimental Procedures Determination of reduced protein content An accurate determination of protein concentrations is a crucial prerequisite for the reliability of bioanalytical assays. Metal binding proteins with surface-exposed CxxC motifs are known to be susceptible for oxidative disulphide formation so that, in such cases, the determination of reduced CxxC content is pivotal. For this application, an assay based on the reaction of free thiols with Ellman’s reagent (DTNB) and subsequent colorimetric detection was suggested and can be considered the reference method (Xiao and Wedd, 2010). We propose an alternative method that utilizes the high affinity copper binding characteristic of our reduced MBD1 or MBD2 domains. Prior to our experiments, we discovered that, due to their high affinities, both MBDs remove copper completely from a [Cu(I)-BCA2]3- complex. Thus, in an equimolar mixture of BCA and either MBD with a substoichiometric amount of Cu(I), more than 99% of the copper is bound to the respective protein. As a consequence, this allows measuring the protein concentration by photometrically detecting the decay of [Cu(I)-BCA2]3- absorption in a premixed solution after addition of a defined volume of protein solution. We compared our test to the established DTNB assay and came up with insignificant deviations. Also, due to the high absorption coefficient of ε358nm = 42000 M-1 cm-1, detection via BCA is more sensitive than a regular Ellman assay. In addition, we used the assay to monitor the oxidation of protein over the course of our titration experiment and came up with oxidation levels of less than 5 %. 7 Supplementary References Xiao, Z., and Wedd, A.G. (2010) The challenges of determining metal-protein affinities. Nat Prod Rep 27: 768–89. 8